Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(23)00019-4/fulltext
0
0
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium - The Lancet
+ 63 more
2/14/23 at 6:30am
Organization
The Lancet
Authors
Details
56 words
Summarize
Health Conditions
Health
Breakthrough SARS-CoV
COVID
mRNA
Cancer Consortium
Vaccination against COVID-19, especially with additional doses, is a fundamental strategy in the prevention of adverse outcomes including death, among patients with cancer.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...